How do we know when health begins to slip into disease? IMMEDIATE aims to answer this question by exploring the “health-to-disease” transition in chronic inflammatory conditions. The project draws on expertise from across Europe to analyse diet-microbiome-metabolite-immune axis. This complex interaction refers to how an individual's diet, gut microbiota, metabolites, and immune system can influence their health.
Through AI-powered predictions, the consortium is building a platform to personalise prevention for conditions such as obesity, diabetes, cardiovascular, kidney and neurodegenerative diseases. The goal: empower people to take more control of their wellbeing and prevent disease long before the first symptoms occur.
